Sugar cookies sold in 20 states recalled for potential wood contamination: See map
The voluntary recall for the Favorite Day Bakery Frosted Sugar Cookies was issued on July 22 by Give and Go Prepared Foods Corp. in Canada, according to the FDA. Favorite Day is a private label brand sold at Target.
In total, 803 cases are being recalled due to the potential foreign contamination.
The cookies, which could potentially contain wood, were distributed across 20 different states and Washington, D.C., the notice stated.
The recall is classified as a Class II recall, meaning the product "may cause temporary or medically reversible adverse health consequences," according to the FDA.
A press release was not issued for the recall, but as of Sunday, Aug. 10, the recall is ongoing.
Target did not immediately respond to a request for comment from USA TODAY on Aug. 10.
The cookies were sold in the following states and districts:
The recalled cookies, Favorite Day Bakery Frosted Sugar Cookies, 10 count, were distributed by Target and produced in Canada.
The cookies are a part of Lot 25195, with the UPC number 85239-41250 3. The packs of cookies have varying Best By Dates, as that is determined by when the retailer removed the cookies from the freezers, according to the notice.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
19 minutes ago
- The Hill
FDA may pull authorization for Pfizer COVID shot for kids under 5
The Food and Drug Administration (FDA) is considering revoking the authorization of Pfizer's COVID-19 vaccine for healthy children under 5 years old, the company confirmed Wednesday. The move would add another barrier for parents who want to vaccinate healthy children, as shots from Moderna and Novavax were approved for more limited populations. In May, Health and Human Services Secretary Robert F. Kennedy Jr. said that the Centers for Disease Control and Prevention (CDC) would no longer recommend COVID-19 vaccines for healthy children or pregnant women. The CDC then updated its immunization schedule to reflect that children with no underlying health condition 'may receive' COVID-19 vaccines after consulting with a health care provider — what's known as 'shared decision-making.' If FDA pulls its emergency use authorization, Pfizer's vaccine would no longer be available to any children younger than 5. Right now, Moderna and Novavax shots could be administered 'off label' to healthy children. 'We are currently in discussions with the agency on potential paths forward and have requested that the EUA for this age group remain in place for the 2025-2026 season,' a Pfizer spokesman told The Hill. 'It is important to note that these deliberations are not related to the safety and efficacy of the vaccine which continues to demonstrate a favorable profile,' the company added. The Guardian first reported on the FDA's potential move. In a statement to The Hill, HHS said it wouldn't comment on potential changes. 'The COVID-19 pandemic ended with the expiration of the federal public health emergency in May 2023. We do not comment on potential, future regulatory changes. Unless officially announced by HHS, discussion about future agency action should be regarded as pure speculation,' HHS spokesman Andrew Nixon said. Pfizer has had full FDA approval for its COVID-19 vaccine for individuals age 12 and older since 2022.
Newsweek
2 hours ago
- Newsweek
Diabetes Warning Issued Over Insulin Pump Error
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A medical device manufacturer has issued an urgent correction for select insulin pumps due to a possible error that could result in insulin not being delivered, the U.S. Food and Drug Administration (FDA) announced. Tandem Diabetes Care, Inc., based in California, said the error appears as a Malfunction 16 alarm to users, and may stop insulin delivery. It can also halt communication between the insulin pump and the continuous glucose monitoring (CGM) device. Newsweek contacted Tandem Diabetes Care, Inc. for comment by email outside of regular working hours. Stock image. Tandem Diabetes Care, Inc. has issued a correction for select insulin pumps due to a possible error that could result in insulin not being delivered. Stock image. Tandem Diabetes Care, Inc. has issued a correction for select insulin pumps due to a possible error that could result in insulin not being delivered. Jens Kalaene/picture-alliance/dpa/AP Why It Matters The FDA said that if the error is not addressed it could lead to hyperglycemia - high blood sugar - in users due to insulin not being delivered. "In severe cases of hyperglycemia, the user may require hospitalization or intervention from a medical professional," it said. Hyperglycemia symptoms include extreme thirst, blurry vision, weakness, dry mouth, headaches, and frequent urination, according to the Centers for Disease Control and Prevention. What To Know The device affected by the urgent correction is the following: t:slim X2 insulin pumps. As of August 12, there had been 700 confirmed adverse events - incidents of confirmed high blood sugar or an event requiring medical intervention - and 59 reported injuries related to the device error, according to the FDA. No deaths had been reported. The FDA said that notices were sent directly to customers across the U.S. between July 22 and 24 with instructions on what to do in the event of a Malfunction 16 alarm. The company is set to release a software update to boost early detection of speaker failures, according to the FDA. The update will also introduce persistent vibration alerts to reduce potential safety risks. What People Are Saying Tandem Diabetes Care, Inc. said in its urgent medical device correction notice: "A Malfunction 16 will stop insulin delivery and terminate communication between the insulin pump and the CGM device, as well as the Tandem t:slim mobile app. If not addressed, this could result in hyperglycemia due to the malfunction resulting in the stoppage of insulin delivery and real time CGM Estimated Glucose Values (EGVs) and CGM trends. In severe cases of hyperglycemia, the user may require hospitalization or intervention from a medical professional. "Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail, or by fax." What Happens Next The company will notify affected pump users when the software update is available and request that the update is completed. Users who have concerns about their pumps can contact the company on techsupport@ or call 1-877-801-6901.
Business Wire
3 hours ago
- Business Wire
New Survey Reveals Pediatricians Overwhelmingly Prefer Genexa's Ingredients Over Children's Tylenol
ATLANTA--(BUSINESS WIRE)--In a category long dominated by legacy brands and artificial additives, a new national survey reveals a powerful shift: U.S. pediatricians overwhelmingly prefer the ingredient profiles in Genexa's pediatric pain and fever liquid medicines over those in Children's Tylenol ® top-selling comparable products. Genexa is the first clean medicine company, revolutionizing the over-the-counter (OTC) medicine aisle by making medicine with the same effective active ingredients as the leading brands, but without any artificial additives. The results of this study—drawn from a double-blind national survey of U.S. pediatricians (FRC 2025) — found that an overwhelming majority of respondents prefer Genexa's oral suspension ingredient profiles for treating their own patient's pain and fever over the ingredient profiles in Tylenol ® 's top-selling comparable products 1. 'This should be a wake-up call for the industry,' said David Johnson, CEO and Co-Founder of Genexa. 'Pediatricians are sending a clear message: it's time to change our medicines. We are so proud to be the first company to make clean medicine because we believe that no parent should have to choose between clean ingredients and effective relief.' A Moment of Trust in Pediatric Care The survey results arrive as transparency and ingredient awareness take center stage for parents and healthcare providers. With 88% of parents identifying pediatricians as their most trusted source for children's health advice 2, these pediatrician preference results signal a strong alignment between medical guidance and parental values. 'Fewer artificial additives isn't a trend, it's a clinical and parental priority,' said Dr. Shayna Smith, board-certified pediatrician and Genexa partner. 'Genexa reflects what we as doctors want to see more of: clean, simple, and effective formulas for acute symptom relief.' The Brand at the Center of a Clean Medicine Movement These findings reinforce broader market trends: clean label products, those made with familiar, simple ingredients and without artificial additives, are growing faster than their conventional counterparts 3. Genexa is leading that shift in the medicine aisle, offering children's medicine from pain relievers to cold and flu treatments that are made with the same effective ingredients as traditional brands, but without additives such as artificial preservatives, artificial sweeteners, dyes, or common allergens. With high standards for safety and efficacy, Genexa gives families a new choice that aligns with their health priorities without compromise. 'Knowing that the medical professionals who have made a commitment to children's health prefer our ingredients is incredibly validating,' added Johnson. 'We hope this empowers even more parents to make the switch to clean medicine.' Genexa's full line of products are available at retailers nationwide including Target, Walmart, Whole Foods, Walgreens, CVS, and more as well as Amazon. For more information on the survey results and to learn more about Genexa's commitment to clean medicine, please visit About Genexa: Founded with the goal of revolutionizing the medicine aisle, Genexa makes medicines with the same effective active ingredients as leading brands, but without artificial additives including artificial preservatives, sweeteners, and dyes. Made in the USA with globally sourced non-GMO ingredients, Genexa medicines are certified gluten-free and free of the top 9 common allergens. As a Certified B Corp, Genexa is leading the clean medicine movement and setting a new standard for what goes into children's and family health products. 1 The ingredient lists that the pediatricians reviewed in the children's pain and fever category were from the following products: Children's Tylenol Pain + Fever Suspension (Dye Free Cherry); Children's Tylenol Pain + Fever Suspension (Dye Free Natural Apple); Children's Tylenol Pain + Fever Suspension (Grape); Genexa Kids' Pain & Fever (Blueberry and Cherry). The ingredient lists that the pediatricians reviewed in the infants' pain and fever category were from the following products: Infants' Tylenol Pain + Fever Suspension (Dye Free Cherry); Infants' Tylenol Pain + Fever Suspension (Grape); Genexa Infants' Pain & Fever (Blueberry and Cherry). 2 2023 RAPID National Survey, Stanford University, 3 2024 Clean Label Products Driving Retail Sales as They Gain Preference Among Consumers, Acosta Group,
